Ann Oncol

1. VAN DER KRUIJSSEN DEW, Elias SG, van de Ven PM, van Rooijen KL, et al
   Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase 3 CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
   Ann Oncol. 2024 Jun 7:S0923-7534(24)00722-1. doi: 10.1016/j.annonc.2024.
   

   >> Share

   
   

   
   Ann Surg

2. BOOTH A, Brinton D, Donahue C, Westfal M, et al
   Extended Pharmacologic Prophylaxis for Venous Thromboembolism after Colon Cancer Surgery is Associated with Improved Long-term Survival: A Natural Experiment in the Chemotherapeutic Benefit of Heparin Derivatives.
   Ann Surg. 2024 Jun 11. doi: 10.1097/SLA.0000000000006376.
   

   >> Share

   
   

   
   Ann Surg Oncol

3. JANCZEWSKI LM, Asare EA, Goodman KA
   Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer.
   Ann Surg Oncol. 2024;31:4155-4158.
   

   >> Share

   
   
4. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
   ASO Visual Abstract: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
   Ann Surg Oncol. 2024;31:4466-4467.
   

   >> Share

   
   
5. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
   ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases-A Nationwide Population-Based Study.
   Ann Surg Oncol. 2024;31:4749-4750.
   

   >> Share

   
   
6. SHAPERA E, Ross S, Pattilachan T, Christodoulou M, et al
   Robotic Biliary Stricturoplasty and Roux-en-Y Hepaticojejunostomy After Hepatic Artery Infusion Pump Injury.
   Ann Surg Oncol. 2024;31:4449-4451.
   

   >> Share

   
   
7. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
   Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for Colorectal Liver Metastases.
   Ann Surg Oncol. 2024;31:4436-4444.
   

   >> Share

   
   
8. EL ASMAR A, Kamdem L, Khaled C, Liberale G, et al
   ASO Author Reflections: Histological Growth Patterns of Colorectal Peritoneal Metastases Significantly Affect Prognosis in Patients Presenting for Curative-Intent Cytoreductive Surgery.
   Ann Surg Oncol. 2024;31:4558-4559.
   

   >> Share

   
   
9. BLANCO ASENSIO N, Aliseda Jover D, Marti-Cruchaga P, Lapuente F, et al
   Anatomical Left Hepatectomy Extended to Caudate Lobe due to Colorectal Metastasis with Intrabiliary Growth: Securing Optimal Margins with a Laennec's Capsule Approach and Vein-Guided Resection.
   Ann Surg Oncol. 2024;31:4447-4448.
   

   >> Share

   
   
10. SANKARAN R, O'Connor J, Nuliyalu U, Diaz A, et al
    Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Ann Surg Oncol. 2024;31:4339-4348.
    

    >> Share

    
    
11. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
    Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2024;31:4413-4426.
    

    >> Share

    
    

    
    BMC Cancer

12. NIU Y, Wen L, Yang Y, Zhang Y, et al
    Diagnostic performance of Node Reporting and Data System (Node-RADS) for assessing mesorectal lymph node in rectal cancer by CT.
    BMC Cancer. 2024;24:716.
    

    >> Share

    
    
13. ZHAN ZQ, Huang ZM, Lan QW, Luo YH, et al
    Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target.
    BMC Cancer. 2024;24:714.
    

    >> Share

    
    

    
    Cancer

14. SUN V, Guthrie KA, Crane TE, Arnold KB, et al
    SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
    Cancer. 2024;130:2384-2394.
    

    >> Share

    
    
15. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    

    >> Share

    
    
16. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    

    >> Share

    
    

    
    Cancer Lett

17. HUANG C, Tan H, Wang J, Huang L, et al
    beta-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1alpha-mediated angiogenesis.
    Cancer Lett. 2024;593:216940.
    

    >> Share

    
    
18. YUAN M, Zhang C, Chen S, Ye S, et al
    PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1.
    Cancer Lett. 2024;597:217007.
    

    >> Share

    
    
19. CHEN Q, Chen J, Deng Y, Bi X, et al
    Personalized prediction of postoperative complication and survival among Colorectal Liver Metastases Patients Receiving Simultaneous Resection using machine learning approaches: A multi-center study.
    Cancer Lett. 2024;593:216967.
    

    >> Share

    
    

    
    Cancer Res

20. LI L, Jiang D, Liu H, Guo C, et al
    Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression.
    Cancer Res. 2024 Jun 11. doi: 10.1158/0008-5472.CAN-23-1878.
    

    >> Share

    
    

    
    Clin Cancer Res

21. LENTZ RW, Friedrich TJ, Blatchford PJ, Jordan KR, et al
    A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite stable colorectal cancer.
    Clin Cancer Res. 2024 Jun 13. doi: 10.1158/1078-0432.CCR-24-0090.
    

    >> Share

    
    
22. SLATER S, Bryant A, Aresu M, Begum R, et al
    Tissue-free liquid biopsies combining genomic and methylation signals for minimal residual disease detection in patients with early colorectal cancer from the UK TRACC Part B study.
    Clin Cancer Res. 2024 Jun 12. doi: 10.1158/1078-0432.CCR-24-0226.
    

    >> Share

    
    

    
    Dis Colon Rectum

23. COLOMBARI R, Perez-Carpio C, Sanchez Rodriguez M, Martinez J, et al
    Preoperative Planning of D3 Right Colectomy With 3-Dimensional Vascular Reconstruction.
    Dis Colon Rectum. 2024;67:e1446-e1447.
    

    >> Share

    
    
24. ZENG X, Zhang R, Jiang W, Li C, et al
    Local Excision Versus Radical Resection for Grade 2 Rectal Neuroendocrine Tumors: A Multicenter Propensity Score-Matched Analysis.
    Dis Colon Rectum. 2024;67:911-919.
    

    >> Share

    
    
25. PUNMEECHAO P, Mongkhonsupphawan A, Riansuwan W
    Transanal Excision: Tips and Tricks.
    Dis Colon Rectum. 2024;67:e1455.
    

    >> Share

    
    
26. KOHRMAN NM, Wlodarczyk JR, Ding L, McAndrew NP, et al
    Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
    Dis Colon Rectum. 2024;67:920-928.
    

    >> Share

    
    
27. MIDHA N, Althaf S, Sugoor P
    Fluorescence-Guided Selective Autonomic Nerve-Preserving Robotic Total Mesorectal Excision: Redefining Technology and Techniques.
    Dis Colon Rectum. 2024;67:e1456-e1457.
    

    >> Share

    
    
28. EVANS C
    Expert Commentary on Kaposi Sarcoma of the Anus: What Does the Colorectal Surgeon Need to Know?
    Dis Colon Rectum. 2024;67:876-877.
    

    >> Share

    
    
29. PEPONIS T, Perry WRG, Kelley SR
    Ischiorectal Fossa Tumors: 30-year Single-Institution Experience.
    Dis Colon Rectum. 2024;67:896-902.
    

    >> Share

    
    
30. BOLSHINSKY V, Sweet DE, Vitello DJ, Jia X, et al
    Using CT-Based Pelvimetry and Visceral Obesity Measurements to Predict Total Mesorectal Excision Quality for Patients Undergoing Rectal Cancer Surgery.
    Dis Colon Rectum. 2024;67:929-939.
    

    >> Share

    
    
31. CAO AMY, Lonne MLR, Moloney JM, Stevenson ARL, et al
    Sutured Transanal Mucosectomy and Plication Procedure.
    Dis Colon Rectum. 2024;67:e1449.
    

    >> Share

    
    
32. FAIREN ORO C, Favuzza J
    Kaposi Sarcoma of the Anus: What Does the Colorectal Surgeon Need to Know?
    Dis Colon Rectum. 2024;67:873-875.
    

    >> Share

    
    
33. MCHUGH FT, Ryan EJ, Ryan OK, Tan J, et al
    Management Strategies for Malignant Left-Sided Colonic Obstruction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Propensity Score Matching Studies.
    Dis Colon Rectum. 2024;67:878-894.
    

    >> Share

    
    
34. LEE GC
    Management Strategies for Malignant Left-Sided Colonic Obstruction: A Systematic Review and Network Meta-analysis of Randomized Control Trials and Propensity Score-Matching Studies.
    Dis Colon Rectum. 2024;67:895.
    

    >> Share

    
    

    
    Eur J Cancer

35. SWARTJES H, Sijtsma FPC, Elferink MAG, van Erning FN, et al
    Corrigendum to "Trends in incidence, treatment, and relative survival of colorectal cancer in the Netherlands between 2000 and 2021'' Volume 205, July 2024, 114104.
    Eur J Cancer. 2024 Jun 11:114155. doi: 10.1016/j.ejca.2024.114155.
    

    >> Share

    
    

    
    Eur J Surg Oncol

36. GAO Z, Qi X, Wang R, Wen Z, et al
    Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108474.
    

    >> Share

    
    
37. GUO Z, Zhang Z
    Reply to "Improving machine learning predictions for metastases in colorectal cancer".
    Eur J Surg Oncol. 2024 May 24:108441. doi: 10.1016/j.ejso.2024.108441.
    

    >> Share

    
    

    
    Gastrointest Endosc

38. BAILE-MAXIA S, Mangas-Sanjuan C, Ladabaum U, Ardila CS, et al
    RISK FACTORS FOR METACHRONOUS COLORECTAL CANCER OR ADVANCED LESIONS AFTER ENDOSCOPIC RESECTION OF SERRATED POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Gastrointest Endosc. 2024 Jun 6:S0016-5107(24)03257.
    

    >> Share

    
    

    
    Int J Colorectal Dis

39. CARVALHO A, Limbert M, Cabral F, Fareleira A, et al
    The impact of methylene blue in colon cancer: a retrospective multicentric study.
    Int J Colorectal Dis. 2024;39:90.
    

    >> Share

    
    
40. OUCHI K, Takahashi S, Sasaki K, Yoshida Y, et al
    Genome-wide DNA methylation status is a predictor of the efficacy of anti-EGFR antibodies in the second-line treatment of metastatic colorectal cancer: Translational research of the EPIC trial.
    Int J Colorectal Dis. 2024;39:89.
    

    >> Share

    
    

    
    J Clin Oncol

41. ANTONIOTTI C, Rossini D, Pietrantonio F, Salvatore L, et al
    Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.
    J Clin Oncol. 2024 Jun 12:JCO2302728. doi: 10.1200/JCO.23.02728.
    

    >> Share

    
    

    
    J Natl Cancer Inst

42. SONG Y, Loomans-Kropp H, Baugher RN, Somerville B, et al
    Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome.
    J Natl Cancer Inst. 2024;116:957-965.
    

    >> Share

    
    
43. YATES J, Schaufelberger H, Steinacher R, Schar P, et al
    DNA-methylation variability in normal mucosa: a field cancerization marker in patients with adenomatous polyps.
    J Natl Cancer Inst. 2024;116:974-982.
    

    >> Share

    
    

    
    J Pathol

44. GEURTS BS, Zeverijn LJ, van Berge Henegouwen JM, van der Wijngaart H, et al
    Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
    J Pathol. 2024;263:288-299.
    

    >> Share

    
    
45. PASTOR-MORATE D, Amigo-Moran L, Garranzo-Asensio M, Rejas-Gonzalez R, et al
    DeltaNp73 and its effector targets promote colorectal peritoneal carcinosis and predict survival.
    J Pathol. 2024;263:328-337.
    

    >> Share

    
    

    
    Lancet Oncol

46. YU JH, Xiao BY, Li DD, Jiang W, et al
    Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study.
    Lancet Oncol. 2024 Jun 6:S1470-2045(24)00203.
    

    >> Share

    
    

    
    Oncogene

47. FENG M, Chai C, Hao X, Lai X, et al
    Inherited KDM6A(A649T) facilitates tumor-immune escape and exacerbates colorectal signet-ring cell carcinoma outcomes.
    Oncogene. 2024;43:1757-1768.
    

    >> Share

    
    

    
    PLoS One

48. SEUFFERLEIN T, Lausser L, Stein A, Arnold D, et al
    Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial.
    PLoS One. 2024;19:e0304324.
    

    >> Share

    
    
49. PROMSUT K, Sangtanoo P, Srimongkol P, Saisavoey T, et al
    A novel peptide derived from Zingiber cassumunar rhizomes exhibits anticancer activity against the colon adenocarcinoma cells (Caco-2) via the induction of intrinsic apoptosis signaling.
    PLoS One. 2024;19:e0304701.
    

    >> Share

    
    
50. DARWISH MK, Allayeh AK, Ahmed AE, Abdelmaksoud MDE, et al
    Case-control study: Unveiling human polyomaviruses and papillomavirus in Egyptian colorectal cancer patients.
    PLoS One. 2024;19:e0304147.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share